|
CIT expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.08200000000525E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.499280E-03 |
| Normal-vs-Stage2 |
2.698600E-01 |
| Normal-vs-Stage3 |
2.474200E-02 |
| Normal-vs-Stage4 |
1.79254999999046E-05 |
| Stage1-vs-Stage2 |
7.518800E-01 |
| Stage1-vs-Stage3 |
5.924600E-01 |
| Stage1-vs-Stage4 |
6.378400E-03 |
| Stage2-vs-Stage3 |
5.636800E-01 |
| Stage2-vs-Stage4 |
1.393370E-01 |
| Stage3-vs-Stage4 |
2.749000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.015620E-04 |
| Normal-vs-AfricanAmerican |
4.896000E-03 |
| Normal-vs-Asian |
9.804800E-04 |
| Caucasian-vs-AfricanAmerican |
9.872800E-01 |
| Caucasian-vs-Asian |
5.210300E-02 |
| AfricanAmerican-vs-Asian |
1.015200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.97893999999144E-05 |
| Normal-vs-Female |
1.635610E-02 |
| Male-vs-Female |
2.447600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.002900E-03 |
| Normal-vs-Extreme_Weight |
2.149500E-02 |
| Normal-vs-Obese |
2.242100E-03 |
| Normal-vs-Extreme_Obese |
4.29656310529936E-13 |
| Normal_Weight-vs-Extreme_Weight |
5.494200E-01 |
| Normal_Weight-vs-Obese |
8.228400E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.820600E-03 |
| Extreme_Weight-vs-Obese |
6.219600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.78929999997235E-06 |
| Obese-vs-Extreme_Obese |
4.86580000003123E-06 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.589000E-04 |
| Normal-vs-Age(41-60Yrs) |
7.186000E-02 |
| Normal-vs-Age(61-80Yrs) |
8.73540000334572E-08 |
| Normal-vs-Age(81-100Yrs) |
6.194400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.150430E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.694800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.585800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.723800E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.645800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.727600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.58210000000114E-05 |
| Normal-VS-Type2 PRCC |
9.477900E-02 |
| Normal-VS-KIRP CIMP |
3.83849999999741E-05 |
| Normal-VS-Unclassified PRCC |
1.523070E-03 |
| Type1 PRCC-VS-Type2 PRCC |
3.833800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.455600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
6.271800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.379900E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.837400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
2.217600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.470200E-02 |
| Normal-vs-N1 |
3.90300003427768E-09 |
| Normal-vs-N2 |
8.399500E-03 |
| N0-vs-N1 |
4.017900E-02 |
| N0-vs-N2 |
1.395030E-01 |
| N1-vs-N2 |
8.002400E-01 |
|
|
